Treace(TMCI) Prnewswire·2025-04-22 18:58Core Viewpoint - A class action lawsuit has been filed against Treace Medical Concepts, Inc for alleged securities fraud and unlawful business practices [2]. Group 1: Lawsuit Details - The lawsuit involves Treace Medical and certain officers and/or directors accused of engaging in securities fraud or other unlawful business practices [2]. - Investors who purchased Treace Medical securities during the Class Period can request to be appointed as Lead Plaintiff by June 10, 2025 [3]. Group 2: Financial Performance - On May 7, 2024, Treace Medical lowered its full-year 2024 revenue guidance from a range of 225 million down to 211 million [3]. - The company cited competition from minimally invasive osteotomy and Lapiplasty "knockoffs" as headwinds affecting Lapiplasty growth [3]. Group 3: Stock Market Reaction - Following the revenue guidance reduction, Treace Medical's stock price fell by 4.17 per share on May 8, 2024, with unusually high trading volume [4].